Filing Details
- Accession Number:
- 0001019056-17-000276
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-03-09 13:36:33
- Reporting Period:
- 2016-12-06
- Filing Date:
- 2017-03-09
- Accepted Time:
- 2017-03-09 13:36:33
- Original Submission Date:
- 2016-12-08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704159 | Vbi Vaccines Inc. | VBIV | Biological Products, (No Disgnostic Substances) (2836) | 930589534 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1164426 | Joseph Edelman | C/O Perceptive Advisors Llc 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No | |
1224962 | Perceptive Advisors Llc | 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No | |
1249675 | Ltd Fund Master Sciences Life Perceptive | C/O Perceptive Advisors Llc 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-12-06 | 3,383,955 | $3.05 | 6,245,725 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2016-12-06 | 363,771 | $4.13 | 363,771 | $4.13 |
Common Stock | Warrant | Acquisiton | 2016-12-06 | 1,341,282 | $3.36 | 1,341,282 | $3.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
727,542 | 2016-12-06 | 2021-12-06 | No | 4 | P | Indirect |
2,068,824 | 2016-12-06 | 2021-12-06 | No | 4 | P | Indirect |
Footnotes
- This Form 4/A is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund. Mr. Edelman is the managing member of the Advisor. This transaction reflects the purchase of common stock and warrants of the issuer in a private placement from the issuer. The previous Form 4 misstated the securities held by the Master Fund.
- This amount reported in Table I reflects the amount of securities held by the Master Fund immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. The amount reported in Table II reflects the amount of securities held by Perceptive Credit Holdings, LP (the "Credit Fund). In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Credit Fund is reported herein.
- Edelman is the control person of the general partner of the Credit Fund. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.